CURIS, INC. (CRIS) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 4.31M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $4.31M | (m) | (m) |
| 2026-03-31 | (m) | $7.06M | (m) | (m) |
| 2025-12-31 | (m) | $9.44M | (m) | (m) |
| 2025-09-30 | (m) | $11.65M | (m) | (m) |
| 2025-06-30 | (m) | $11.40M | (m) | (m) |
| 2025-03-31 | (m) | $11.20M | (m) | (m) |
| 2024-12-31 | (m) | $10.91M | (m) | (m) |
| 2024-09-30 | (m) | $10.26M | (m) | (m) |
| 2024-06-30 | (m) | $10.16M | (m) | (m) |
| 2024-03-31 | (m) | $9.81M | (m) | (m) |
| 2023-12-31 | (m) | $10.02M | (m) | (m) |
| 2023-09-30 | (m) | $10.21M | (m) | (m) |
| 2023-06-30 | (m) | $10.21M | (m) | (m) |
| 2023-03-31 | (m) | $10.40M | (m) | (m) |
| 2022-12-31 | (m) | $10.16M | (m) | (m) |
| 2022-09-30 | (m) | $10.41M | (m) | (m) |
| 2022-06-30 | (m) | $10.62M | (m) | (m) |
| 2022-03-31 | (m) | $10.52M | (m) | (m) |
| 2021-12-31 | (m) | $10.65M | (m) | (m) |
| 2021-09-30 | (m) | $10.54M | (m) | (m) |
| 2021-06-30 | (m) | $10.24M | (m) | (m) |
| 2021-03-31 | (m) | $10.31M | (m) | (m) |
| 2020-12-31 | (m) | $10.84M | (m) | (m) |
| 2020-09-30 | (m) | $11.10M | (m) | (m) |
| 2020-06-30 | (m) | $11.21M | (m) | (m) |
| 2020-03-31 | (m) | $10.95M | (m) | (m) |
| 2019-12-31 | (m) | $10.00M | (m) | (m) |
| 2019-09-30 | (m) | $9.47M | (m) | (m) |
| 2019-06-30 | (m) | $9.46M | (m) | (m) |
| 2019-03-31 | (m) | $9.73M | (m) | (m) |
| 2018-12-31 | (m) | $10.43M | (m) | (m) |
| 2018-09-30 | (m) | $10.94M | (m) | (m) |
| 2018-06-30 | (m) | $10.53M | (m) | (m) |
| 2018-03-31 | (m) | $10.23M | (m) | (m) |
| 2017-12-31 | (m) | $9.90M | (m) | (m) |
| 2017-09-30 | (m) | $9.00M | (m) | (m) |
| 2017-06-30 | (m) | $8.31M | (m) | (m) |
| 2017-03-31 | (m) | $7.93M | (m) | (m) |
| 2016-12-31 | (m) | $7.53M | (m) | (m) |
| 2016-09-30 | (m) | $7.26M | (m) | (m) |
| 2016-06-30 | (m) | $7.54M | (m) | (m) |
| 2016-03-31 | (m) | $7.95M | (m) | (m) |
| 2015-12-31 | (m) | $7.88M | (m) | (m) |
| 2015-09-30 | (m) | $7.78M | (m) | (m) |
| 2015-06-30 | (m) | $7.50M | (m) | (m) |
| 2015-03-31 | (m) | $10.22M | (m) | (m) |
| 2014-12-31 | (m) | $9.84M | (m) | (m) |
| 2014-09-30 | (m) | $9.37M | (m) | (m) |
| 2014-06-30 | (m) | $14.81M | (m) | (m) |
| 2014-03-31 | (m) | $15.42M | (m) | (m) |
| 2013-12-31 | (m) | $15.00M | (m) | (m) |
| 2013-09-30 | (m) | $15.16M | (m) | (m) |
| 2013-06-30 | (m) | $8.54M | (m) | (m) |
| 2013-03-31 | (m) | $7.49M | (m) | (m) |
| 2012-12-31 | (m) | $16.97M | (m) | (m) |
| 2012-09-30 | (m) | $29.37M | (m) | (m) |
| 2012-06-30 | (m) | $28.94M | (m) | (m) |
| 2012-03-31 | (m) | $24.99M | (m) | (m) |
| 2011-12-31 | (m) | $14.76M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $16.00M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $8.59M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |